The Irvine, Calif.-based non-invasive monitoring technology developer anticipates product revenue in the first quarter of 2020 to range between $265 million and $271 million, reflecting growth of 14.9% to 17.5% compared to the first quarter of last year. Masimo plans to discuss its complete first-quarter results after the market closes on April 28.
Due to the uncertainties caused by the coronavirus outbreak and the potential impact it may have on Masimo’s business, the company said in a news release that it is not offering a 2020 guidance.
Masimo said there are potential positive impacts, including increased demand for products from both direct and OEM customers, which continued into the first days of the second quarter. However, negative impacts may include potential interruptions in manufacturing operations for both the company and its suppliers, along with reductions in future demand as a result of overbuying during the pandemic.
MASI shares were up 2.49% to $181.54 in mid-morning trading today.